The United States will recommend that its citizens use a booster dose of the vaccine against COVID-19.


The Government of Joe Biden analyzes the measure that could be announced this week to prevent a loss of immunity and stop the advance of the Delta variant of the coronavirus.

The United States plans to announce that almost all of its citizens should receive a booster dose of the COVID-19 vaccine eight months after being immunized, a new phase in the vaccination campaign that could begin in mid-September, according to what they gave. Get to know the local media, The New York Times, and The Washington Post.

The two newspapers, which cited officials familiar with the government's decision, suggest that the official announcement could be made this week.

The Government of Joe Biden has concluded that a booster dose is necessary to prevent a loss of immunity and curb the Delta variant of covid-19, which is more contagious and has caused an increase in the number of infected and hospitalizations.

Before it begins, the booster dose must be endorsed by the Food and Drug Administration (FDA), the government agency that approves the use of new drugs, vaccines, and other related products. Public health.

The idea is that Americans receive a booster dose eight months after completing their vaccination schedule.

According to The New York Times, the first doses will go to healthcare personnel and those living in nursing homes or centers for the disabled. Next on the list will be the elderly.

Last Thursday, the FDA authorized the third dose of Pfizer and Moderna for people with a weakened immune system. They have not responded like the general population to vaccines, estimated to be 3% of the country's population.

However, the FDA has not decided whether another dose should be recommended for those immunosuppressed who have received the Johnson & Johnson vaccine, in which only one dose is necessary.

The World Health Organization (WHO) has called for a global moratorium on a third dose of the vaccine until the end of September because it considers that if countries begin to administer it, it will not help the global distribution of serums against the covid, while the Union Europea has ensured that there is still not enough evidence that they are necessary.